GENESCO INC
For the period ended May 2, 2026. Filed Jun 11, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
May 2, 2026 · Filed Jun 11, 2026
GCO$36.79-2.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows - Three Months ended
Condensed Consolidated Statements of Cash Flows
| Three Months Ended | ||
|---|---|---|
| May 2, 2026 | May 3, 2025 | |
| CASH FLOWS FROM OPERATING ACTIVITIES: | ||
| Net loss | $(14,814) | $(21,227) |
| Adjustments to reconcile net loss to net cash used in | ||
| operating activities: | ||
| Depreciation and amortization | 13,247 | 13,393 |
| Deferred income taxes | (51) | 172 |
| Impairment of long-lived assets | — | 34 |
| Share-based compensation expense | 2,814 | 2,994 |
| Other | 1,035 | 359 |
| Changes in working capital and other assets and liabilities: | ||
| Accounts receivable | (7,962) | (3,629) |
| Inventories | (43,220) | (20,206) |
| Prepaids and other current assets | (4,778) | (6,682) |
| Accounts payable | (28,127) | (47,531) |
| Other accrued liabilities | (20,931) | (15,186) |
| Other assets and liabilities | 15 | (3,527) |
| Net cash used in operating activities | (102,772) | (101,036) |
| CASH FLOWS FROM INVESTING ACTIVITIES: | ||
| Capital expenditures | (15,416) | (18,898) |
| Net cash used in investing activities | (15,416) | (18,898) |
| CASH FLOWS FROM FINANCING ACTIVITIES: | ||
| Borrowings under revolving credit facility | 52,670 | 188,805 |
| Payments on revolving credit facility | (10,933) | (68,184) |
| Shares repurchased related to share repurchase plan | — | (12,566) |
| Shares repurchased related to taxes for share-based awards | (2,106) | (664) |
| Change in overdraft balances | 525 | (62) |
| Additions to deferred financing costs | (140) | — |
| Net cash provided by financing activities | 40,016 | 107,329 |
| Effect of foreign exchange rate fluctuations on cash | (111) | 346 |
| Net decrease in cash and cash equivalents | (78,283) | (12,259) |
| Cash and cash equivalents at beginning of period | 105,405 | 34,007 |
| Cash and cash equivalents at end of period | $27,122 | $21,748 |
| Supplemental information: | ||
| Interest paid | $384 | $736 |
| Income taxes paid | 221 | 385 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.